[{"from": "human", "value": "Please give me some details about this molecule. [C][C][=Branch1][C][=O][O][C][=C][Branch1][P][C][=C][C][=Branch1][Ring2][=C][Ring1][=Branch1][C][Branch1][C][F][Branch1][C][F][F][C][=Branch1][C][=O][O]"}, {"from": "gpt", "value": "The molecule is a 2-acetoxy-4-trifluoromethylbenzoic acid and it is an aspirin chemically-related molecule but not a derivative. The benefits of this agent are the lack of action over the arachidonic acid pathway, the driven production of nitric oxide and the increase of cyclic nucleotide concentration on endothelial cells. The latest translates into the expansion of peripheral blood vessels. It is very important as a secondary prevention of ischemic stroke by offering a lower risk of bleeding. It was developed by  J. Uriach and Company and even though it is commercialized in different countries it is not approved by the FDA, EMA or HealthCanada."}]